15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.
Kyushu Institute Of Technology
Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Cnrs
Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors.
Stony Brook University
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
University Of London
Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
China Pharmaceutical University
Natural products, small molecules, and genetics in tuberculosis drug development.
National Institute Of Diabetes And Digestive And Kidney Diseases
Agonodepsides a and B: two new depsides from a filamentous fungus F7524.
Institute Of Molecular And Cell Biology
Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.
University Of Minnesota
Biexponential kinetics of (R)-alpha-[3H]methylhistamine binding to the rat brain H3 histamine receptor.
Schering-Plough Research Institute